We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+22.13%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$6.56B
AUM Growth
+$999M
Cap. Flow
+$144M
Cap. Flow %
2.19%
Top 10 Hldgs %
37.58%
Holding
4,118
New
286
Increased
1,783
Reduced
1,210
Closed
187

Top Buys

Rank Stock Value
1
AVDE icon
Avantis International Equity ETF
AVDE
+$10.8M
2
VFLO icon
VictoryShares Free Cash Flow ETF
VFLO
+$8.86M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$8.55M
4
NVDA icon
NVIDIA
NVDA
+$7.51M
5
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.47M

Top Sells

Rank Stock Value
1
BILZ icon
PIMCO Ultra Short Government Active ETF
BILZ
+$10.3M
2
HON icon
Honeywell
HON
+$6.08M
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$5.5M
4
CVBF icon
CVB Financial
CVBF
+$2.65M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$2.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.26%
2 Technology 17.37%
3 Healthcare 9%
4 Financials 6.03%
5 Communication Services 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WRD
3851
WeRide Inc
WRD
$1.91B
$76 ﹤0.01%
13
-346
-96% -$2.5K
HYLN icon
3852
Hyliion Holdings
HYLN
$689M
$74 ﹤0.01%
14
– –
QNCX icon
3853
Quince Therapeutics
QNCX
$30.8M
$55 ﹤0.01%
3
-1
-25% -$23
LOOP icon
3854
Loop Industries
LOOP
$20.8M
$48 ﹤0.01%
50
– –
SEGG
3855
Sports Entertainment Gaming Global Corp
SEGG
$9.06M
$47 ﹤0.01%
7
– –
CRDF icon
3856
Cardiff Oncology
CRDF
$81.7M
$46 ﹤0.01%
+35
New +$56
ACB
3857
Aurora Cannabis
ACB
$246M
$45 ﹤0.01%
16
– –
BBN icon
3858
BlackRock Taxable Municipal Bond Trust
BBN
$960M
$45 ﹤0.01%
+2
New +$32
WHWK
3859
Whitehawk Therapeutics
WHWK
$239M
$37 ﹤0.01%
8
– –
KOSS icon
3860
Koss Corp
KOSS
$32.8M
$36 ﹤0.01%
9
-1
-10% -$4
NNOX icon
3861
Nano X Imaging
NNOX
$61.3M
$35 ﹤0.01%
30
– –
HOLO icon
3862
MicroCloud Hologram
HOLO
$37.8M
$31 ﹤0.01%
20
– –
RNAC icon
3863
Cartesian Therapeutics
RNAC
$263M
$31 ﹤0.01%
103
– –
LAB icon
3864
Standard BioTools
LAB
$285M
$30 ﹤0.01%
37
– –
ECF
3865
Ellsworth Growth & Income Fund
ECF
$172M
$28 ﹤0.01%
2
– –
OTLY
3866
Oatly Group
OTLY
$402M
$28 ﹤0.01%
3
– –
RNA
3867
Atrium Therapeutics
RNA
$180M
$27 ﹤0.01%
2
-74
-97% -$967
CLGN icon
3868
CollPlant Biotechnologies
CLGN
$6.45M
$25 ﹤0.01%
7
– –
ANGI icon
3869
Angi Inc
ANGI
$191M
$24 ﹤0.01%
4
-3,618
-100% -$22.3K
SCLX icon
3870
Scilex Holding
SCLX
$36.6M
$23 ﹤0.01%
3
– –
CTRM icon
3871
Castor Maritime
CTRM
$24.1M
$21 ﹤0.01%
10
– –
VIXY icon
3872
ProShares VIX Short-Term Futures ETF
VIXY
$217M
$21 ﹤0.01%
1
– –
TPST icon
3873
Tempest Therapeutics
TPST
$15M
$20 ﹤0.01%
18
– –
AVTX icon
3874
Avalo Therapeutics
AVTX
$977M
$18 ﹤0.01%
1
– –
ONL
3875
Orion Office REIT
ONL
$149M
$17 ﹤0.01%
6
– –
153 154
155
156 157

Similar funds

AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $6.51B AUM 25.32% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return

Parallel Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Parallel Advisors held 4,118 positions worth $6.56B, up 18% from $5.56B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Parallel Advisors's Q2 2026 filing shows 286 new, 1,783 increased, 1,210 reduced and 187 closed positions. Its largest new stake was Honeywell Aerospace: 22,925 shares worth $5.07M. The largest sale was PIMCO Ultra Short Government Active ETF, an estimated $10.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2026 buy was Honeywell Aerospace: 22,925 shares worth $5.07M.
  • Parallel Advisors added most to Avantis International Equity ETF in Q2 2026, an estimated $10.8M increase.
  • Parallel Advisors's biggest Q2 2026 reduction was PIMCO Ultra Short Government Active ETF, cutting an estimated $10.3M.
  • Parallel Advisors fully exited iShares MSCI China ETF in Q2 2026, selling an estimated $747K.
  • Parallel Advisors's ten largest holdings make up 38% of its $6.56B portfolio in Q2 2026.
  • Parallel Advisors opened 286 new positions and closed 187 in Q2 2026.
  • Parallel Advisors's portfolio value rose 18% quarter-over-quarter to $6.56B.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.